Hepatic schistosomiasis and chronic active hepatitis

Area of Science:

• Hepatology
• Immunology
• Infectious Diseases

Background:

• Schistosomiasis is a parasitic disease that can affect the liver.
• Chronic active hepatitis (CAH) is a serious liver inflammation.
• Autoimmune mechanisms are being investigated for their role in CAH development within schistosomiasis.

Purpose of the Study:

• To investigate the presence of liver membrane antibody (LMA) in patients with schistosomiasis.
• To determine if LMA is associated with chronic active hepatitis (CAH) in schistosomiasis patients.
• To explore the potential role of autoimmune mechanisms in CAH associated with schistosomiasis.

Main Methods:

• Sera from two groups of patients were examined: Group I (hepatic schistosomiasis without CAH) and Group II (CAH with intestinal Mansoniasis, no hepatic infection).
• All patients were tested for Hepatitis B surface antigen (HBsAg).
• Presence of liver membrane antibody (LMA) and organ-non-specific autoantibodies were assessed. Antibodies to hepatitis B core antigen (anti-HBc) were also evaluated.

Main Results:

• Circulating LMA was detected in 68% of Group I patients and 60% of Group II patients.
• Low titres of organ-non-specific autoantibodies were found in about a third of patients but did not correlate with LMA.
• No correlation was observed between LMA and anti-HBc, ruling out occult or recent hepatitis B virus infection as a factor in LMA production.

Conclusions:

• The high prevalence of LMA in both patient groups suggests a potential association with schistosomiasis-related liver disease.
• Further long-term follow-up of LMA-positive patients is needed to ascertain if it predicts the future development of CAH in hepatic schistosomiasis.
• Autoimmune factors, indicated by LMA, warrant further investigation in the pathogenesis of CAH in schistosomiasis.